PMID: 9630681Jun 19, 1998Paper

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease

Biochimica Et Biophysica Acta
Y M KuoAlex E Roher

Abstract

Experimental evidence increasingly implicates the beta-amyloid peptide in the pathogenesis of Alzheimer's disease. Beta-amyloid filaments dramatically accumulate in the neuritic plaques and vascular deposits as the result of the brain's inability to clear these structures. In this paper, we demonstrate that in addition to the intrinsic stability of A beta N-42, the time dependent generation of irreversibly associated A beta dimers and tetramers incorporated into A beta filaments are themselves resistant to proteolytic degradation. The presence of post-translational modifications such as isomerization of aspartyls 1 and 7, cyclization of glutamyl 3 to pyroglutamyl and oxidation of methionyl 35, further contribute to the insolubility and stability of A beta. All these factors promote the accumulation of neurotoxic amyloid in the brains of patients with Alzheimer's disease, and should be considered in therapeutic strategies directed towards the dissociation of the brain's A beta filaments.

References

Nov 1, 1991·Biophysical Journal·P E FraserD A Kirschner
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A RoherD KuKuruga
Nov 1, 1994·Journal of Neuroscience Research·S WebsterJ Rogers
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A E RoherM J Ball
Feb 15, 1993·Archives of Biochemistry and Biophysics·D L MillerK Iqbal
Feb 23, 1996·The Journal of Biological Chemistry·Y M KuoA E Roher
Aug 22, 1997·The Journal of Biological Chemistry·W Garzon-RodriguezC G Glabe
Aug 29, 1997·The Journal of Biological Chemistry·D M WalshD B Teplow
Oct 31, 1998·Protein Engineering·M O ChaneyA E Roher

❮ Previous
Next ❯

Citations

Oct 14, 2009·Journal of Neural Transmission·Oliver WirthsThomas A Bayer
Jun 5, 2003·Journal of the American Society for Mass Spectrometry·Ziqiang GuanRay Bakhtiar
Aug 2, 2002·Neuroreport·Sonia S Jung, William E Van Nostrand
Oct 12, 2010·Molecular Neurodegeneration·Chera L MaaroufAlex E Roher
May 1, 2013·PloS One·Vasanthy VigneswaraWayne G Carter
Jul 18, 2014·Alzheimer's Research & Therapy·Markus P Kummer, Michael T Heneka
Mar 29, 2014·Journal of the American Society for Mass Spectrometry·Alice L Pilo, Scott A McLuckey
May 8, 2014·Cellular and Molecular Life Sciences : CMLS·E HubinK Pauwels
Sep 28, 2010·International Journal of Alzheimer's Disease·Oliver Wirths, Thomas A Bayer
Jul 18, 2006·Biochemical and Biophysical Research Communications·Liang YeAndrew Lockhart
Oct 4, 2011·The Journal of Biological Chemistry·Sadim JawharThomas A Bayer
Jun 30, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Tyler A Kokjohn, Alex E Roher
Jun 29, 2001·Journal of Peptide Science : an Official Publication of the European Peptide Society·A B ClippingdaleC J Barrow
Sep 30, 2004·Biophysical Journal·B UrbancN V Dokholyan
Aug 29, 2006·The American Journal of Pathology·R Lyle PattonAlex E Roher
Nov 30, 2006·Drug Discovery Today·Andrew Lockhart
Apr 13, 2007·Neuro-degenerative Diseases·Verena H Finder, Rudi Glockshuber
Jun 19, 2016·Journal of Neurochemistry·Mauricio R GalianoMarta E Hallak
Oct 13, 2006·Antioxidants & Redox Signaling·Anna M BarronRalph N Martins
Sep 16, 2006·Neuropathology and Applied Neurobiology·T OideK Arima
Jan 31, 2018·Acta Neuropathologica Communications·Zsolt DatkiJanos Kalman
May 25, 2005·International Journal of Experimental Pathology·Christa J MaynardQiao-Xin Li
Sep 6, 2005·Biological & Pharmaceutical Bulletin·Takahiko ShimizuTakuji Shirasawa
Nov 23, 2005·The Journal of Biological Chemistry·Séverine ZirahSylvie Rebuffat
Jun 1, 2006·Expert Review of Neurotherapeutics·Anthony R WhiteAshley I Bush
Apr 25, 2007·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Hila ShovalEhud Gazit
Jan 24, 2012·The Journal of Biological Chemistry·Jessica L WittnamThomas A Bayer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.